The trial of COVID vaccine developed in India has started at the Delhi AIIMS. The first dose of covaxin was given to a man of 30 years old. The second dose will be given after two weeks of observation. His first two hours will be under the full supervision of doctors.
India tests 'COVAXIN' in Humans; The trial of COVID-19 Vaccine Developed in India: First dose was given to a man of 30
He will be sent home but will remain under observation. covaxin was developed by Hyderabad-based Bharat Biotech in collaboration with ICMR and the National Institute of Virology Led by Dr. Krishna Illa, Bharat Biotech has been active in research for over 20 years.
The opinions posted here are not those of BizGlob. The author is solely responsible for the comments. According to the IT policy of the Central Government, insulting and obscene language against an individual, community, religion, or country is a punishable offence. Such expressions will be prosecuted.
Add your comments to India tests 'COVAXIN' in Humans; The trial of COVID-19 Vaccine Developed in India: First dose was given to a man of 30
Send your enquiries, articles, copyright issues, or advertisement requests to bizglobadvt@gmail.com
Disclaimer: All content on this website, including article, video, photographs, biography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.
